Inglés

Eligibility Criteria

5 formularios  
Inclusion and exclusion criteria
Descripción

Inclusion and exclusion criteria

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251
Samples were genotyped using the Illumina OncoArray Beadchip 500K SNP custom array. Samples with call rates <95% and samples with extreme heterozygosity (>4.9 standard deviations from the mean for the reported ethnicity) were excluded. Samples were also excluded if they were of non-European ancestry using multi-dimensional scaling analysis. The sample quality control process is described in detail in Milne et al, Identification of ten variants associated with risk of estrogen receptor negative breast cancer, Nat Genet (in press). Related individuals are retained in the sample. The OncoArray SNP quality control process is described in detail in Amos et al, The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers, Cancer Epidemiol Biomarkers Prev. 2017. PubMed_link
Descripción

Samples were genotyped using the Illumina OncoArray Beadchip 500K SNP custom array. Samples with call rates <95% and samples with extreme heterozygosity (>4.9 standard deviations from the mean for the reported ethnicity) were excluded. Samples were also excluded if they were of non-European ancestry using multi-dimensional scaling analysis. The sample quality control process is described in detail in Milne et al, Identification of ten variants associated with risk of estrogen receptor negative breast cancer, Nat Genet (in press). Related individuals are retained in the sample. The OncoArray SNP quality control process is described in detail in Amos et al, The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers, Cancer Epidemiol Biomarkers Prev. 2017. PubMed_link

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C5441552
UMLS CUI [1,2]
C1136352
UMLS CUI [1,3]
C0006826
UMLS CUI [1,4]
C1709626
UMLS CUI [1,5]
C0041366
UMLS CUI [1,6]
C0370003
UMLS CUI [1,7]
C1285573
UMLS CUI [1,8]
C4687476
UMLS CUI [1,9]
C0752046
UMLS CUI [1,10]
C2828389
UMLS CUI [1,11]
C1518422
UMLS CUI [1,12]
C1257905
UMLS CUI [1,13]
C0681930
UMLS CUI [1,14]
C0034378
UMLS CUI [1,15]
C0035647
UMLS CUI [1,16]
C4733092
UMLS CUI [1,17]
C1880171
Volver a la parte superior de la página

Similar models

Eligibility Criteria

5 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Samples were genotyped using the Illumina OncoArray Beadchip 500K SNP custom array. Samples with call rates <95% and samples with extreme heterozygosity (>4.9 standard deviations from the mean for the reported ethnicity) were excluded. Samples were also excluded if they were of non-European ancestry using multi-dimensional scaling analysis. The sample quality control process is described in detail in Milne et al, Identification of ten variants associated with risk of estrogen receptor negative breast cancer, Nat Genet (in press). Related individuals are retained in the sample. The OncoArray SNP quality control process is described in detail in Amos et al, The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers, Cancer Epidemiol Biomarkers Prev. 2017. PubMed_link
Item
Samples were genotyped using the Illumina OncoArray Beadchip 500K SNP custom array. Samples with call rates <95% and samples with extreme heterozygosity (>4.9 standard deviations from the mean for the reported ethnicity) were excluded. Samples were also excluded if they were of non-European ancestry using multi-dimensional scaling analysis. The sample quality control process is described in detail in Milne et al, Identification of ten variants associated with risk of estrogen receptor negative breast cancer, Nat Genet (in press). Related individuals are retained in the sample. The OncoArray SNP quality control process is described in detail in Amos et al, The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers, Cancer Epidemiol Biomarkers Prev. 2017. PubMed_link
boolean
C5441552 (UMLS CUI [1,1])
C1136352 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,3])
C1709626 (UMLS CUI [1,4])
C0041366 (UMLS CUI [1,5])
C0370003 (UMLS CUI [1,6])
C1285573 (UMLS CUI [1,7])
C4687476 (UMLS CUI [1,8])
C0752046 (UMLS CUI [1,9])
C2828389 (UMLS CUI [1,10])
C1518422 (UMLS CUI [1,11])
C1257905 (UMLS CUI [1,12])
C0681930 (UMLS CUI [1,13])
C0034378 (UMLS CUI [1,14])
C0035647 (UMLS CUI [1,15])
C4733092 (UMLS CUI [1,16])
C1880171 (UMLS CUI [1,17])
Volver a la parte superior de la página